Position in CRSP
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$3,822,217
-$88,322 QoQ
Shares Held
70,081
-14.7% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 521 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $894,401,954 across 107 Biotechnology names. CRSP ranks #36 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
487,627 | $242,218,959 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
109,838 | $68,488,386 | |
| 3 | EXEL |
Exelixis, Inc.
|
949,669 | $51,671,490 | |
| 4 | ARGX |
Argenx SE
|
55,346 | $51,348,358 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
136,395 | $41,058,986 | |
| 6 | INSM |
INSMED Inc
|
336,997 | $35,930,620 | |
| 7 | RPRX |
Royalty Pharma plc
|
513,096 | $28,769,292 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
713,946 | $25,266,548 |
All Filings in CRSP
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,822,217 | 70,081 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $3,910,539 | 82,206 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,966,635 | 56,572 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $4,561,911 | 70,389 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $3,304,698 | 67,942 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $2,316,013 | 68,058 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $2,205,458 | 56,033 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,573,423 | 54,777 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,195,290 | 40,646 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,816,166 | 41,317 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,465,626 | 39,387 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,299,061 | 28,620 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,011,249 | 18,013 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $883,794 | 19,540 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $995,315 | 24,485 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,427,374 | 21,842 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,326,487 | 21,828 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $1,198,216 | 19,089 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,244,383 | 16,421 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $1,774,650 | 15,855 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $3,495,366 | 21,591 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $1,941,679 | 15,935 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,451,176 | 9,478 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $336,734 | 4,026 | Shares | Sole | 2020-10-09 | |
| No filing history on record for this holder in this stock. | ||||||